Grey Wolf Therapeutics completes £2.5 million Series A2 financing to accelerate development of therapies targeting ERAP2
January 9, 2020

January 9, 2020
January 8, 2020
December 18, 2019
December 17, 2019
December 12, 2019
December 5, 2019
December 3, 2019
November 19, 2019
November 7, 2019
January 9, 2026
Cycle Pharmaceuticals Ltd (Cycle) and Inceptua Group (Inceptua) have announced the expansion of their partnership to make NITYR® (nitisinone) tablets ...
December 4, 2025
The study reinforces that ME is a complex multisystemic condition with a clear genetic basis and lays the foundation for future clinical trials that c...
October 30, 2025
Lonza to acquire Redberry SAS, an innovative company specializing in rapid microbiology testing solutions Acquisition to include Red One™ solid-phase ...

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225